Marshall Wace
ASXC

Marshall Wace’s Asensus Surgical, Inc. ASXC Stock Holding History

Marshall Wace’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-32,700
Closed -$21K – 3961
2022
Q1 		$21K Buy
+32,700
New +$25.2K ﹤0.01% 3263
2021
Q2 		– Sell
-270,390
Closed -$879K – 3209
2021
Q1 		$879K Buy
+270,390
New +$979K ﹤0.01% 1730

Other funds holding ASXC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Marshall Wace's ASXC Position: Q2 2022 in Review

Marshall Wace sold out of Asensus Surgical, Inc. (ASXC) in Q2 2022, closing a stake of 32,700 shares — an estimated $21K sold.

Marshall Wace first reported a position in ASXC in Q1 2021 and held it in 2 quarters. The position peaked at $879K in Q1 2021. 91 funds tracked by Wall St. Rank hold ASXC as of Q2 2022.

  • Marshall Wace reported no remaining Asensus Surgical, Inc. position as of Q2 2022 after selling out during the quarter.
  • Marshall Wace sold 32,700 Asensus Surgical, Inc. shares in Q2 2022, an estimated $21K.
  • Marshall Wace first reported a position in Asensus Surgical, Inc. in Q1 2021 and held it in 2 quarters.
  • Marshall Wace's Asensus Surgical, Inc. position peaked at $879K in Q1 2021.
  • 91 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q2 2022.

Based on Marshall Wace's 13F filing for Q2 2022, filed 15 Aug 2022.